Operating profit before amortization: fortressbiotech.com (FBIO)

Public company logo of Fortress Biotech (FBIO)

Fortress Biotech, Inc. (FBIO) protects its assets through patent diversification, utilizing the outsourcing of clinical trials via external vendors. The GURU.Markets platform features this chart, where actual operating profit reflects a level of 0.00, helping to assess the business's solvency. The incubator model distributes pricing power among subsidiaries, which minimizes risks stemming from the failure of any single drug.

Fortress Biotech (FBIO) Profit before payment of interest, taxes and amortization: for the period 11/23/2025 - 11/11/2026

Summary analytical data breakdowns for Fortress Biotech (FBIO)

- market price and analyst price targets:
Stock Price Fortress Biotech Corp|FBIO - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Fortress Biotech|FBIO - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Fortress Biotech|FBIO - Company Book Value|Market-to-Book Ratio fortressbiotech.com|FBIO - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Fortress Biotech, Inc.|FBIO - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Fortress Biotech Inc|FBIO - Company Total Debt|Debt to Net Assets Ratio Fortress Biotech|FBIO - Company Long-Term Debt|Short-Term Debt Fortress Biotech|Immediate Liquidity Ratio fortressbiotech.com
- earnings and market multiples details:
FBIO - Net Profit|Future Profit Fortress Biotech, Inc.|FBIO - Price to Earnings Ratio|Projected Price to Earnings Ratio fortressbiotech.com|FBIO - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Fortress Biotech|FBIO - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Fortress Biotech|FBIO - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year fortressbiotech.com|FBIO - Net earnings per share growth this year|Expected net earnings per share growth next year Fortress Biotech, Inc.
Fundamental company valuation:Fortress Biotech Corp
Original product of Fortress

This indicator measures cash flow from core operations before taxes and interest, allowing investors to assess the business's actual ability to generate cash. By analyzing the operating profit trends amid the implementation of automated laboratories and AI solutions at Fortress Biotech, Inc. (FBIO), one can determine whether technological modernization is translating into sustainable fundamental growth in capitalization.

Competitors of Fortress Biotech, Inc. (FBIO)

Operating profit EBITDA Novocure NVCR|DRTS - Profit before payment of interest, taxes and amortization|ACRV (acrivon.com) - Operating profit before amortization|ALLR: Operating profit EBITDA